Although numerous mechanisms such as drug efflux and detoxification, DNA repair activation, and apoptosis inhibition are implicated in cisplatin resistance [10, 11], retaining MKP1 expression and suppressing JNK activity may blunt cytotoxicity induced by cisplatin in cancer cells. Here, DUSP1 is linked to cancer.